Journal Information

Statistics

Follow this link to access the full text of the article

Brief Report

Survival of first line biological and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in Chile

Supervivencia de terapias antirreumáticas de primera línea con fármacos biológicos y sintéticos dirigidos en pacientes con artritis reumatoide en Chile

Marcos Cruces Olivara, Allan D. Burboab, Yolanda M. Gómezb,

Corresponding author

ygomez@ubiobio.cl

Corresponding author.

a Servicio de Inmunología y Reumatología del Hospital Regional de Copiapó, Copiapó, Chile

b Departamento de Estadística, Facultad de Ciencias, Universidad del Bío-Bío, Concepción, Chile

Read

258

Times
was read the article

Total PDF

258

Total HTML

Share statistics

Article information

ISSN: 21735743
Original language: English

DOI:10.1016/j.reumae.2025.501946

The statistics are updated each day

Year/Month	Html	Pdf	Total
2026 1	97	0	97
2025 12	161	0	161

Follow this link to access the full text of the article

Statistics

Subscribe to our newsletter